STRUCTURE THERAPEUTICS INC (GPCR) Stock Analyst Earnings Estimates
NASDAQ:GPCR - Nasdaq - US86366E1064 - ADR - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A -100.00% | N/A | N/A 14.92% | N/A 1,312.90% | N/A 48.43% | N/A 63.65% | N/A 53.36% | |||||
| EBITDA YoY % growth | -15.906M | -37.624M -136.54% | -52.284M -38.96% | -102.48M -96.01% | N/A -56.03% | N/A -24.52% | N/A -30.76% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -15.906M | -37.696M -136.99% | -52.561M -39.43% | -102.775M -95.53% | N/A -55.58% | N/A -4.63% | N/A -60.64% | N/A -30.90% | N/A -9.35% | N/A 78.80% | N/A 288.60% | N/A 249.15% | N/A 96.08% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -2.13 40.84% | N/A 61.71% | N/A 0.02% | N/A -65.70% | N/A 0.36% | N/A -8.33% | N/A 187.94% | N/A 122.47% | N/A 86.95% | N/A 55.78% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.23 65.41% | -0.24 -25.62% | -0.26 -42.37% | -0.29 -44.46% | -0.31 -35.39% | -0.34 -40.38% | -0.34 -33.93% | -0.35 -19.86% | -0.35 -14.52% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |||||
| EBITDA Q2Q % growth | -48.253M -57.18% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -48.331M -55.94% | -50.794M -58.66% | -53.077M -59.32% | -57.695M -25.87% | -64.171M -32.78% | -59.27M -16.69% | -58.297M -9.83% | -57.1M 1.03% | -57.221M 10.83% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.20 67.74% | -0.19 | -0.01 | -5.49% |
| Q2 2024 Q2Q % growth | -0.18 70.00% | -0.23 | 0.05 | 22.26% |
| Q1 2024 Q2Q % growth | -0.19 24.00% | -0.21 | 0.02 | 11.60% |
| Q4 2023 Q2Q % growth | -0.66 42.11% | -0.21 | -0.45 | -211.09% |
| Q3 2023 Q2Q % growth | -0.62 | -0.30 | -0.32 | -108.76% |
| Q2 2023 Q2Q % growth | -0.60 | -0.28 | -0.32 | -112.05% |
| Q1 2023 Q2Q % growth | -0.25 | -0.42 | 0.17 | 40.70% |
| Q4 2022 Q2Q % growth | -1.14 | -0.84 | -0.30 | -36.30% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | 7.038M | -7.038M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -2.13% | 13.97% | 0.55% | -2.64% |
| Revenue | N/A | N/A | N/A | N/A |